Actively Recruiting
Inaticabtagene Autoleucel Injection Treatment for Adult Relapsed or Refractory Acute Lymphocytic Leukemia
Led by Juventas Cell Therapy Ltd. · Updated on 2024-09-19
200
Participants Needed
10
Research Sites
260 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This clinical trial is a non-interventional, observational, multicenter, post-marketing real-world study to evaluate the efficacy and safety of Inaticabtagene Autoleucel Injection in Chinese adult patients with relapsed or refractory B-cell acute lymphoblastic leukemia.
CONDITIONS
Official Title
Inaticabtagene Autoleucel Injection Treatment for Adult Relapsed or Refractory Acute Lymphocytic Leukemia
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Diagnosed with relapsed or refractory B-cell acute lymphoblastic leukemia
- Eligible for receiving commercial Inaticabtagene Autoleucel Injection treatment as determined by the investigator
- Voluntarily agree to participate and sign informed consent (or legal guardian consents if participant lacks full legal capacity)
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 10 locations
1
Peking University People's Hospital
Beijing, Beijing Municipality, China, 100000
Actively Recruiting
2
Peking University Third Hospital
Beijing, Beijing Municipality, China, 100000
Actively Recruiting
3
Zhujiang Hospital of Southern Medical University
Guangzhou, Guangdong, China
Actively Recruiting
4
Henan Cancer Hospital Affiliated Cancer Hospital of Zhengzhou University
Zhengzhou, Henan, China
Actively Recruiting
5
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, China
Actively Recruiting
6
The Affiliated Hospital of Xuzhou Medical University
Xuzhou, Jiangsu, China
Actively Recruiting
7
Qilu Hospital of Shandong university
Jinan, Shandong, China
Actively Recruiting
8
Tongji Hospital of Tongji University
Shanghai, Shanghai Municipality, China
Actively Recruiting
9
West China School of Medicine/West China Hospital of Sichuan University
Chengdu, Sichuan, China
Actively Recruiting
10
Institute of Hematology & Blood Diseases Hospital
Tianjin, Tianjin Municipality, China
Actively Recruiting
Research Team
Q
Qinghan Wang, master
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here